Comment on

• Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.

  Antman EM. Antman EM. Circulation. 1994 Oct;90(4):1624-30. doi: 10.1161/01.cir.90.4.1624. Circulation. 1994. PMID: 7923644 Clinical Trial.
• Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.

  [No authors listed] [No authors listed] Circulation. 1994 Oct;90(4):1631-7. doi: 10.1161/01.cir.90.4.1631. Circulation. 1994. PMID: 7923645 Clinical Trial.
• Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).

  Neuhaus KL, von Essen R, Tebbe U, Jessel A, Heinrichs H, Mäurer W, Döring W, Harmjanz D, Kötter V, Kalhammer E, et al. Neuhaus KL, et al. Circulation. 1994 Oct;90(4):1638-42. doi: 10.1161/01.cir.90.4.1638. Circulation. 1994. PMID: 7923646 Clinical Trial.